Qiang Fu
Concepts (410)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urethra | 3 | 2025 | 91 | 2.800 |
Why?
| Osteoblasts | 10 | 2024 | 451 | 2.080 |
Why?
| Osteoclasts | 11 | 2024 | 424 | 1.790 |
Why?
| Bone Resorption | 7 | 2024 | 297 | 1.650 |
Why?
| Somatostatin | 4 | 2014 | 31 | 1.590 |
Why?
| RANK Ligand | 13 | 2024 | 179 | 1.490 |
Why?
| Carrier Proteins | 7 | 2015 | 302 | 1.450 |
Why?
| Vitamin E | 6 | 2020 | 76 | 1.300 |
Why?
| Animals | 49 | 2025 | 13100 | 1.220 |
Why?
| Hydrogels | 2 | 2024 | 17 | 1.200 |
Why?
| Chromans | 5 | 2014 | 35 | 1.180 |
Why?
| Mice | 38 | 2025 | 5658 | 1.180 |
Why?
| Tissue Scaffolds | 2 | 2024 | 36 | 1.170 |
Why?
| Radiation-Protective Agents | 7 | 2020 | 72 | 1.160 |
Why?
| Wound Healing | 3 | 2024 | 201 | 1.140 |
Why?
| Cell-Derived Microparticles | 2 | 2017 | 20 | 1.060 |
Why?
| Recombinant Fusion Proteins | 4 | 2014 | 186 | 1.050 |
Why?
| Serum Albumin | 3 | 2014 | 58 | 1.000 |
Why?
| Solubility | 2 | 2024 | 72 | 0.990 |
Why?
| Disease Models, Animal | 3 | 2024 | 1411 | 0.990 |
Why?
| Urethral Stricture | 1 | 2025 | 21 | 0.970 |
Why?
| Anastomosis, Surgical | 1 | 2025 | 66 | 0.960 |
Why?
| Tissue Engineering | 2 | 2024 | 67 | 0.960 |
Why?
| Atenolol | 1 | 2024 | 14 | 0.960 |
Why?
| Urologic Surgical Procedures, Male | 1 | 2025 | 40 | 0.960 |
Why?
| Theca Cells | 1 | 2024 | 1 | 0.960 |
Why?
| Biological Availability | 2 | 2024 | 99 | 0.950 |
Why?
| Primary Ovarian Insufficiency | 1 | 2024 | 4 | 0.950 |
Why?
| Osteocytes | 3 | 2024 | 214 | 0.950 |
Why?
| Mitochondrial Dynamics | 1 | 2024 | 18 | 0.940 |
Why?
| Pichia | 3 | 2014 | 8 | 0.930 |
Why?
| Bariatric Surgery | 1 | 2025 | 41 | 0.930 |
Why?
| Ultrasonography, Interventional | 1 | 2025 | 137 | 0.900 |
Why?
| Laparoscopy | 1 | 2025 | 170 | 0.830 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2025 | 550 | 0.780 |
Why?
| Rats, Sprague-Dawley | 3 | 2024 | 1578 | 0.750 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 137 | 0.700 |
Why?
| Mice, Inbred C57BL | 14 | 2024 | 1777 | 0.690 |
Why?
| Cell Differentiation | 5 | 2024 | 649 | 0.620 |
Why?
| Postoperative Complications | 2 | 2025 | 1018 | 0.600 |
Why?
| Osteogenesis | 3 | 2024 | 353 | 0.600 |
Why?
| Whole-Body Irradiation | 7 | 2021 | 129 | 0.580 |
Why?
| Imipramine | 1 | 2017 | 13 | 0.580 |
Why?
| Osteoporosis, Postmenopausal | 1 | 2017 | 28 | 0.560 |
Why?
| Intestinal Mucosa | 5 | 2021 | 215 | 0.550 |
Why?
| Cell Line | 8 | 2024 | 1010 | 0.540 |
Why?
| Radiation Injuries, Experimental | 3 | 2019 | 81 | 0.540 |
Why?
| Bone Density Conservation Agents | 1 | 2017 | 74 | 0.540 |
Why?
| Parathyroid Hormone | 7 | 2017 | 147 | 0.520 |
Why?
| Bone Remodeling | 2 | 2015 | 149 | 0.520 |
Why?
| Intestines | 6 | 2021 | 169 | 0.510 |
Why?
| Subcellular Fractions | 1 | 2015 | 34 | 0.510 |
Why?
| Membrane Glycoproteins | 4 | 2006 | 244 | 0.500 |
Why?
| Cell Communication | 1 | 2015 | 69 | 0.480 |
Why?
| Escherichia coli | 3 | 2024 | 191 | 0.480 |
Why?
| Mevalonic Acid | 1 | 2014 | 5 | 0.470 |
Why?
| Chitosan | 2 | 2024 | 36 | 0.470 |
Why?
| Male | 27 | 2025 | 25437 | 0.470 |
Why?
| Somatostatin-28 | 1 | 2014 | 3 | 0.470 |
Why?
| Zinc | 2 | 2024 | 52 | 0.470 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2014 | 42 | 0.460 |
Why?
| Receptors, Somatostatin | 1 | 2014 | 3 | 0.460 |
Why?
| Emulsions | 1 | 2014 | 25 | 0.460 |
Why?
| Calcium | 3 | 2014 | 401 | 0.450 |
Why?
| Enhancer Elements, Genetic | 3 | 2011 | 58 | 0.440 |
Why?
| Protein Engineering | 1 | 2013 | 18 | 0.440 |
Why?
| Gene Expression Regulation | 6 | 2015 | 964 | 0.440 |
Why?
| Endothelium, Vascular | 4 | 2010 | 251 | 0.440 |
Why?
| Pancreas | 2 | 2011 | 71 | 0.420 |
Why?
| Humans | 28 | 2025 | 49898 | 0.400 |
Why?
| Up-Regulation | 3 | 2015 | 446 | 0.400 |
Why?
| Osteoprotegerin | 3 | 2023 | 52 | 0.390 |
Why?
| Apoptosis | 4 | 2014 | 1092 | 0.380 |
Why?
| Radiation, Ionizing | 4 | 2022 | 97 | 0.370 |
Why?
| Mitochondria | 3 | 2024 | 395 | 0.360 |
Why?
| Transcription Factors | 3 | 2024 | 565 | 0.330 |
Why?
| Thrombomodulin | 2 | 2008 | 27 | 0.320 |
Why?
| Mice, Knockout | 7 | 2024 | 835 | 0.310 |
Why?
| Treatment Outcome | 5 | 2025 | 5176 | 0.310 |
Why?
| Female | 19 | 2025 | 26560 | 0.300 |
Why?
| Cyclic AMP Response Element-Binding Protein | 3 | 2006 | 33 | 0.290 |
Why?
| Rats | 5 | 2024 | 3273 | 0.280 |
Why?
| Teriparatide | 1 | 2006 | 10 | 0.270 |
Why?
| Jejunum | 2 | 2021 | 54 | 0.270 |
Why?
| DNA-Binding Proteins | 1 | 2008 | 424 | 0.250 |
Why?
| Intestine, Small | 2 | 2021 | 110 | 0.250 |
Why?
| Lung | 3 | 2025 | 501 | 0.250 |
Why?
| Cynodon | 1 | 2024 | 1 | 0.250 |
Why?
| DNA Shuffling | 1 | 2024 | 1 | 0.250 |
Why?
| Conjunctivitis, Allergic | 1 | 2024 | 1 | 0.240 |
Why?
| Artemisia annua | 1 | 2024 | 1 | 0.240 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2024 | 10 | 0.240 |
Why?
| Epitopes, T-Lymphocyte | 1 | 2025 | 25 | 0.240 |
Why?
| Membrane Transport Proteins | 2 | 2015 | 47 | 0.240 |
Why?
| Hemiptera | 1 | 2024 | 4 | 0.240 |
Why?
| Catechin | 1 | 2024 | 12 | 0.240 |
Why?
| Calorimetry, Differential Scanning | 1 | 2024 | 8 | 0.240 |
Why?
| Pulmonary Alveoli | 1 | 2025 | 27 | 0.240 |
Why?
| Quorum Sensing | 1 | 2024 | 9 | 0.240 |
Why?
| Drug Stability | 1 | 2024 | 34 | 0.240 |
Why?
| Crassostrea | 1 | 2024 | 2 | 0.240 |
Why?
| Maleimides | 1 | 2024 | 8 | 0.240 |
Why?
| Cicatrix | 1 | 2024 | 40 | 0.240 |
Why?
| Biphenyl Compounds | 1 | 2024 | 31 | 0.240 |
Why?
| Pseudomonas Infections | 1 | 2024 | 47 | 0.240 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2024 | 39 | 0.240 |
Why?
| Hyaluronic Acid | 1 | 2024 | 35 | 0.240 |
Why?
| Heat-Shock Proteins | 2 | 2015 | 105 | 0.240 |
Why?
| Pseudomonas aeruginosa | 1 | 2024 | 71 | 0.230 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 197 | 0.230 |
Why?
| Oxidative Stress | 5 | 2013 | 759 | 0.230 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2024 | 17 | 0.230 |
Why?
| Radiation Injuries | 4 | 2010 | 110 | 0.230 |
Why?
| Kidney Tubules | 1 | 2024 | 61 | 0.230 |
Why?
| Biocompatible Materials | 1 | 2024 | 68 | 0.230 |
Why?
| Bone Regeneration | 1 | 2024 | 72 | 0.230 |
Why?
| Ovary | 1 | 2024 | 114 | 0.230 |
Why?
| Staphylococcus aureus | 2 | 2024 | 327 | 0.230 |
Why?
| Testosterone | 1 | 2024 | 137 | 0.230 |
Why?
| Umbilical Cord | 1 | 2024 | 34 | 0.230 |
Why?
| Rabbits | 1 | 2024 | 375 | 0.230 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2025 | 124 | 0.230 |
Why?
| Periosteum | 1 | 2024 | 26 | 0.230 |
Why?
| Lung Diseases | 1 | 2025 | 96 | 0.230 |
Why?
| Fibrosis | 1 | 2024 | 178 | 0.230 |
Why?
| Osteolysis | 1 | 2024 | 75 | 0.230 |
Why?
| Cyclophosphamide | 1 | 2024 | 163 | 0.220 |
Why?
| Lymphatic Vessels | 1 | 2024 | 53 | 0.220 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2025 | 157 | 0.220 |
Why?
| Antihypertensive Agents | 1 | 2024 | 124 | 0.220 |
Why?
| Administration, Oral | 1 | 2024 | 433 | 0.220 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 2003 | 53 | 0.220 |
Why?
| Cells, Cultured | 6 | 2017 | 1587 | 0.220 |
Why?
| Middle Aged | 5 | 2025 | 12285 | 0.220 |
Why?
| Glycoproteins | 2 | 2005 | 115 | 0.210 |
Why?
| Spine | 2 | 2022 | 91 | 0.210 |
Why?
| Osteomyelitis | 1 | 2024 | 125 | 0.210 |
Why?
| Adult | 5 | 2025 | 13346 | 0.200 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 65 | 0.200 |
Why?
| Protein Binding | 4 | 2014 | 656 | 0.200 |
Why?
| Dexamethasone | 1 | 2024 | 424 | 0.200 |
Why?
| Lysosomal-Associated Membrane Protein 2 | 1 | 2022 | 5 | 0.200 |
Why?
| Energy Metabolism | 1 | 2024 | 282 | 0.200 |
Why?
| Indoles | 1 | 2024 | 273 | 0.190 |
Why?
| Molecular Chaperones | 1 | 2022 | 63 | 0.190 |
Why?
| Duodenum | 1 | 2021 | 35 | 0.190 |
Why?
| Staphylococcal Infections | 1 | 2024 | 269 | 0.190 |
Why?
| Ileum | 1 | 2021 | 86 | 0.190 |
Why?
| Cyclic AMP | 2 | 2014 | 92 | 0.180 |
Why?
| Autophagy | 1 | 2022 | 165 | 0.180 |
Why?
| NF-kappa B | 2 | 2024 | 315 | 0.180 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2020 | 60 | 0.170 |
Why?
| Inflammation | 2 | 2024 | 603 | 0.170 |
Why?
| Mice, Inbred BALB C | 2 | 2024 | 296 | 0.170 |
Why?
| RNA, Messenger | 7 | 2013 | 1099 | 0.170 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2019 | 22 | 0.170 |
Why?
| Anti-Bacterial Agents | 1 | 2024 | 742 | 0.160 |
Why?
| Hyperparathyroidism | 2 | 2011 | 31 | 0.160 |
Why?
| Prospective Studies | 1 | 2025 | 2345 | 0.160 |
Why?
| Heptanoic Acids | 2 | 2008 | 34 | 0.160 |
Why?
| Pyrroles | 2 | 2008 | 68 | 0.150 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 4 | 2006 | 30 | 0.150 |
Why?
| Cytokines | 3 | 2024 | 607 | 0.150 |
Why?
| Gene Expression | 4 | 2014 | 612 | 0.150 |
Why?
| Phenotype | 2 | 2024 | 728 | 0.140 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 139 | 0.140 |
Why?
| Bone Density | 4 | 2011 | 383 | 0.140 |
Why?
| Sepsis | 1 | 2019 | 220 | 0.140 |
Why?
| Immunity, Innate | 2 | 2024 | 104 | 0.130 |
Why?
| Obesity | 1 | 2025 | 1096 | 0.130 |
Why?
| Chemokines | 2 | 2019 | 75 | 0.130 |
Why?
| Radiotherapy | 2 | 2007 | 124 | 0.130 |
Why?
| Ovariectomy | 2 | 2014 | 113 | 0.130 |
Why?
| Blotting, Western | 2 | 2015 | 587 | 0.120 |
Why?
| Microscopy, Electron, Transmission | 1 | 2015 | 75 | 0.120 |
Why?
| Microscopy, Confocal | 1 | 2015 | 83 | 0.120 |
Why?
| Transcription Factor CHOP | 1 | 2014 | 7 | 0.120 |
Why?
| Calmodulin | 1 | 2014 | 9 | 0.120 |
Why?
| Dose-Response Relationship, Radiation | 3 | 2010 | 183 | 0.120 |
Why?
| Fermentation | 1 | 2014 | 9 | 0.120 |
Why?
| Injections, Subcutaneous | 1 | 2014 | 51 | 0.110 |
Why?
| Half-Life | 1 | 2014 | 85 | 0.110 |
Why?
| Kinetics | 2 | 2014 | 632 | 0.110 |
Why?
| Phosphorylation | 2 | 2014 | 526 | 0.110 |
Why?
| Intestinal Diseases | 2 | 2019 | 26 | 0.110 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 81 | 0.110 |
Why?
| Endoplasmic Reticulum | 1 | 2014 | 118 | 0.110 |
Why?
| Natriuretic Peptide, Brain | 1 | 2014 | 29 | 0.110 |
Why?
| Polyethylene Glycols | 1 | 2014 | 85 | 0.110 |
Why?
| Ligands | 1 | 2014 | 203 | 0.110 |
Why?
| Protein Transport | 1 | 2014 | 183 | 0.110 |
Why?
| Homeostasis | 1 | 2014 | 202 | 0.110 |
Why?
| Nerve Fibers | 1 | 2013 | 11 | 0.110 |
Why?
| Signal Transduction | 2 | 2014 | 1608 | 0.110 |
Why?
| Dose-Response Relationship, Drug | 2 | 2020 | 1354 | 0.110 |
Why?
| Lymphatic System | 1 | 2013 | 13 | 0.110 |
Why?
| Retrospective Studies | 1 | 2025 | 6123 | 0.100 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2014 | 326 | 0.100 |
Why?
| Immune System | 1 | 2013 | 43 | 0.100 |
Why?
| Genomics | 2 | 2024 | 284 | 0.100 |
Why?
| Flow Cytometry | 1 | 2015 | 470 | 0.100 |
Why?
| Core Binding Factor Alpha 1 Subunit | 3 | 2009 | 43 | 0.100 |
Why?
| Transfection | 1 | 2013 | 354 | 0.100 |
Why?
| Bone Demineralization, Pathologic | 1 | 2011 | 5 | 0.100 |
Why?
| Random Allocation | 2 | 2010 | 285 | 0.100 |
Why?
| Lactation | 1 | 2011 | 58 | 0.100 |
Why?
| Trypsin | 1 | 2011 | 12 | 0.100 |
Why?
| Pentoxifylline | 1 | 2010 | 13 | 0.090 |
Why?
| Skull | 3 | 2024 | 74 | 0.090 |
Why?
| Mice, Transgenic | 3 | 2025 | 543 | 0.090 |
Why?
| Transcription, Genetic | 4 | 2010 | 370 | 0.090 |
Why?
| Lymph Nodes | 1 | 2013 | 257 | 0.090 |
Why?
| Hematopoiesis | 1 | 2010 | 70 | 0.090 |
Why?
| Cell Proliferation | 1 | 2014 | 986 | 0.090 |
Why?
| Interferon-gamma | 1 | 2011 | 176 | 0.090 |
Why?
| Blood Vessels | 1 | 2010 | 71 | 0.090 |
Why?
| Base Sequence | 2 | 2014 | 657 | 0.090 |
Why?
| Molecular Sequence Data | 2 | 2014 | 799 | 0.090 |
Why?
| Radiation Dosage | 3 | 2021 | 157 | 0.090 |
Why?
| Leukocytes | 1 | 2010 | 66 | 0.090 |
Why?
| Cesium Radioisotopes | 1 | 2009 | 4 | 0.080 |
Why?
| Chemokine CXCL9 | 1 | 2009 | 7 | 0.080 |
Why?
| Thermoluminescent Dosimetry | 1 | 2009 | 7 | 0.080 |
Why?
| Bacterial Translocation | 1 | 2009 | 16 | 0.080 |
Why?
| Hydroxymethylglutaryl CoA Reductases | 1 | 2009 | 9 | 0.080 |
Why?
| Time Factors | 3 | 2011 | 2891 | 0.080 |
Why?
| Blood Cells | 1 | 2009 | 43 | 0.080 |
Why?
| Interleukin-12 | 1 | 2009 | 29 | 0.080 |
Why?
| Cerebellum | 1 | 2010 | 132 | 0.080 |
Why?
| Femur | 2 | 2024 | 130 | 0.080 |
Why?
| Cell Lineage | 1 | 2009 | 83 | 0.080 |
Why?
| rho-Associated Kinases | 1 | 2008 | 20 | 0.080 |
Why?
| Citrulline | 1 | 2009 | 96 | 0.080 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 6 | 0.080 |
Why?
| Brain Injuries | 1 | 2010 | 159 | 0.080 |
Why?
| Enzyme Inhibitors | 1 | 2010 | 378 | 0.080 |
Why?
| 14-3-3 Proteins | 1 | 2008 | 19 | 0.080 |
Why?
| Sp1 Transcription Factor | 1 | 2008 | 21 | 0.080 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2008 | 35 | 0.080 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2008 | 51 | 0.080 |
Why?
| Kaplan-Meier Estimate | 1 | 2009 | 463 | 0.070 |
Why?
| MAP Kinase Signaling System | 1 | 2008 | 118 | 0.070 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 98 | 0.070 |
Why?
| Peroxynitrous Acid | 3 | 2013 | 33 | 0.070 |
Why?
| Hypolipidemic Agents | 1 | 2007 | 28 | 0.070 |
Why?
| Simvastatin | 1 | 2007 | 29 | 0.070 |
Why?
| Tissue Plasminogen Activator | 1 | 2008 | 110 | 0.070 |
Why?
| Connective Tissue | 1 | 2006 | 23 | 0.070 |
Why?
| Protein Kinase Inhibitors | 1 | 2008 | 205 | 0.070 |
Why?
| Transcription Initiation Site | 1 | 2006 | 13 | 0.070 |
Why?
| Base Pairing | 1 | 2006 | 27 | 0.070 |
Why?
| Conserved Sequence | 1 | 2006 | 56 | 0.070 |
Why?
| C-Reactive Protein | 1 | 2007 | 143 | 0.070 |
Why?
| Gene Deletion | 1 | 2007 | 267 | 0.070 |
Why?
| Organ Specificity | 1 | 2006 | 106 | 0.070 |
Why?
| Cattle | 1 | 2006 | 207 | 0.070 |
Why?
| Binding Sites | 1 | 2006 | 378 | 0.060 |
Why?
| HLA-DRB1 Chains | 1 | 2025 | 5 | 0.060 |
Why?
| Genome, Plant | 1 | 2024 | 6 | 0.060 |
Why?
| Bone Morphogenetic Proteins | 1 | 2005 | 56 | 0.060 |
Why?
| Vitis | 1 | 2024 | 3 | 0.060 |
Why?
| Organ Size | 2 | 2022 | 223 | 0.060 |
Why?
| Rhinitis, Allergic, Seasonal | 1 | 2024 | 8 | 0.060 |
Why?
| Chick Embryo | 1 | 2024 | 83 | 0.060 |
Why?
| Porosity | 1 | 2024 | 31 | 0.060 |
Why?
| Plant Diseases | 1 | 2024 | 8 | 0.060 |
Why?
| Food Packaging | 1 | 2024 | 7 | 0.060 |
Why?
| Tensile Strength | 1 | 2024 | 30 | 0.060 |
Why?
| Vascular Endothelial Growth Factor C | 1 | 2024 | 4 | 0.060 |
Why?
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2024 | 5 | 0.060 |
Why?
| Aquaculture | 1 | 2024 | 4 | 0.060 |
Why?
| Delayed-Action Preparations | 1 | 2024 | 55 | 0.060 |
Why?
| Polymers | 1 | 2024 | 42 | 0.060 |
Why?
| Phytoplankton | 1 | 2024 | 19 | 0.060 |
Why?
| Diatoms | 1 | 2024 | 20 | 0.060 |
Why?
| Titanium | 1 | 2024 | 47 | 0.060 |
Why?
| Water | 1 | 2024 | 74 | 0.060 |
Why?
| Immunomodulation | 1 | 2024 | 37 | 0.060 |
Why?
| Carcinoma, Transitional Cell | 1 | 2004 | 52 | 0.060 |
Why?
| Fluorocarbons | 1 | 2024 | 49 | 0.060 |
Why?
| Seasons | 1 | 2024 | 81 | 0.060 |
Why?
| Reproduction | 1 | 2024 | 58 | 0.060 |
Why?
| Chondrocytes | 1 | 2024 | 41 | 0.060 |
Why?
| Virulence | 1 | 2024 | 171 | 0.060 |
Why?
| Ureteral Obstruction | 1 | 2024 | 61 | 0.060 |
Why?
| Interleukin-6 | 1 | 2005 | 265 | 0.060 |
Why?
| Inflammasomes | 1 | 2024 | 62 | 0.060 |
Why?
| Allergens | 1 | 2024 | 137 | 0.060 |
Why?
| Multienzyme Complexes | 1 | 2003 | 35 | 0.060 |
Why?
| Stress, Physiological | 1 | 2024 | 173 | 0.060 |
Why?
| Single-Cell Analysis | 1 | 2024 | 63 | 0.060 |
Why?
| Skin | 1 | 2006 | 415 | 0.060 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 67 | 0.050 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2024 | 129 | 0.050 |
Why?
| Metabolomics | 1 | 2024 | 131 | 0.050 |
Why?
| Liver | 1 | 2009 | 1106 | 0.050 |
Why?
| Anti-Inflammatory Agents | 1 | 2024 | 160 | 0.050 |
Why?
| Bone and Bones | 2 | 2007 | 473 | 0.050 |
Why?
| Urinary Bladder Neoplasms | 1 | 2004 | 158 | 0.050 |
Why?
| Estrenes | 1 | 2002 | 13 | 0.050 |
Why?
| Epithelial Cells | 1 | 2024 | 209 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 36 | 0.050 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 223 | 0.050 |
Why?
| Transcription Factor AP-1 | 1 | 2002 | 62 | 0.050 |
Why?
| Transcriptome | 1 | 2024 | 312 | 0.050 |
Why?
| Proteomics | 1 | 2024 | 292 | 0.050 |
Why?
| Cell Respiration | 1 | 2022 | 41 | 0.050 |
Why?
| Calcification, Physiologic | 1 | 2022 | 40 | 0.050 |
Why?
| Sirtuin 3 | 1 | 2022 | 17 | 0.050 |
Why?
| Primates | 1 | 2021 | 20 | 0.050 |
Why?
| Macaca mulatta | 1 | 2021 | 92 | 0.050 |
Why?
| Neoplasm Proteins | 1 | 2003 | 321 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 579 | 0.050 |
Why?
| Nitric Oxide Synthase | 2 | 2010 | 73 | 0.040 |
Why?
| Aging | 1 | 2024 | 669 | 0.040 |
Why?
| Molecular Structure | 1 | 2020 | 293 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2020 | 394 | 0.040 |
Why?
| Endothelial Cells | 2 | 2010 | 256 | 0.040 |
Why?
| Neoplasms | 1 | 2006 | 1233 | 0.030 |
Why?
| Fibroblasts | 2 | 2009 | 352 | 0.030 |
Why?
| Child, Preschool | 1 | 2024 | 3875 | 0.030 |
Why?
| Models, Biological | 2 | 2013 | 719 | 0.030 |
Why?
| Young Adult | 1 | 2024 | 4029 | 0.030 |
Why?
| Receptors, Atrial Natriuretic Factor | 1 | 2014 | 8 | 0.030 |
Why?
| Cyclic GMP | 1 | 2014 | 20 | 0.030 |
Why?
| Gene Order | 1 | 2013 | 13 | 0.030 |
Why?
| Protein Conformation | 1 | 2014 | 165 | 0.030 |
Why?
| Cell Division | 2 | 2005 | 294 | 0.030 |
Why?
| Leukocyte Count | 1 | 2013 | 71 | 0.030 |
Why?
| Nerve Endings | 1 | 2013 | 2 | 0.030 |
Why?
| Adolescent | 1 | 2024 | 6414 | 0.030 |
Why?
| Gene Targeting | 1 | 2013 | 31 | 0.030 |
Why?
| Sympathetic Nervous System | 1 | 2013 | 19 | 0.030 |
Why?
| Neurotransmitter Agents | 1 | 2013 | 35 | 0.030 |
Why?
| Child | 1 | 2024 | 6844 | 0.030 |
Why?
| Mice, 129 Strain | 1 | 2011 | 37 | 0.020 |
Why?
| Glutathione | 1 | 2013 | 296 | 0.020 |
Why?
| GTP Cyclohydrolase | 1 | 2010 | 4 | 0.020 |
Why?
| Colony-Forming Units Assay | 1 | 2010 | 23 | 0.020 |
Why?
| Drug Synergism | 1 | 2010 | 152 | 0.020 |
Why?
| Vesicular Glutamate Transport Protein 2 | 1 | 2010 | 6 | 0.020 |
Why?
| Vascular System Injuries | 1 | 2010 | 37 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 30 | 0.020 |
Why?
| Malondialdehyde | 1 | 2010 | 50 | 0.020 |
Why?
| Deoxyguanosine | 1 | 2010 | 27 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 2010 | 190 | 0.020 |
Why?
| Core Binding Factor beta Subunit | 1 | 2009 | 3 | 0.020 |
Why?
| Embryo, Mammalian | 1 | 2009 | 67 | 0.020 |
Why?
| Imaging, Three-Dimensional | 1 | 2010 | 152 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 73 | 0.020 |
Why?
| Immunoblotting | 1 | 2009 | 116 | 0.020 |
Why?
| Survival Analysis | 1 | 2010 | 670 | 0.020 |
Why?
| Analysis of Variance | 1 | 2010 | 552 | 0.020 |
Why?
| Stromal Cells | 1 | 2009 | 72 | 0.020 |
Why?
| Microarray Analysis | 1 | 2008 | 73 | 0.020 |
Why?
| Muscle, Smooth | 1 | 2008 | 64 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2009 | 210 | 0.020 |
Why?
| Vitamin D | 1 | 2009 | 88 | 0.020 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2010 | 213 | 0.020 |
Why?
| Lymphoid Tissue | 1 | 2007 | 20 | 0.020 |
Why?
| Receptors, Thrombin | 1 | 2007 | 11 | 0.020 |
Why?
| Survival Rate | 1 | 2010 | 905 | 0.020 |
Why?
| Thrombin | 1 | 2007 | 38 | 0.020 |
Why?
| Protein C | 1 | 2007 | 18 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2008 | 579 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2008 | 456 | 0.020 |
Why?
| Abdominal Neoplasms | 1 | 2007 | 16 | 0.020 |
Why?
| Pelvic Neoplasms | 1 | 2007 | 14 | 0.020 |
Why?
| Drug Evaluation, Preclinical | 1 | 2007 | 145 | 0.020 |
Why?
| Gastrointestinal Tract | 1 | 2007 | 101 | 0.020 |
Why?
| Injections | 1 | 2005 | 56 | 0.020 |
Why?
| Histocytochemistry | 1 | 2005 | 47 | 0.020 |
Why?
| Blotting, Northern | 1 | 2005 | 110 | 0.020 |
Why?
| Genetic Markers | 1 | 2005 | 103 | 0.020 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 100 | 0.020 |
Why?
| Absorptiometry, Photon | 1 | 2005 | 152 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2005 | 369 | 0.010 |
Why?
| GTP-Binding Proteins | 1 | 2004 | 93 | 0.010 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2004 | 85 | 0.010 |
Why?
| Lumbar Vertebrae | 1 | 2005 | 97 | 0.010 |
Why?
| bcl-Associated Death Protein | 1 | 2003 | 9 | 0.010 |
Why?
| Incidence | 1 | 2007 | 986 | 0.010 |
Why?
| Dactinomycin | 1 | 2003 | 23 | 0.010 |
Why?
| Culture Media, Conditioned | 1 | 2003 | 48 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2008 | 1028 | 0.010 |
Why?
| Down-Regulation | 1 | 2004 | 342 | 0.010 |
Why?
| Models, Genetic | 1 | 2003 | 174 | 0.010 |
Why?
| Compressive Strength | 1 | 2002 | 12 | 0.010 |
Why?
| Dihydrotestosterone | 1 | 2002 | 12 | 0.010 |
Why?
| HeLa Cells | 1 | 2003 | 257 | 0.010 |
Why?
| Seminal Vesicles | 1 | 2002 | 13 | 0.010 |
Why?
| Orchiectomy | 1 | 2002 | 41 | 0.010 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 116 | 0.010 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 126 | 0.010 |
Why?
| Osteocalcin | 1 | 2002 | 43 | 0.010 |
Why?
| RNA | 1 | 2003 | 169 | 0.010 |
Why?
| Uterus | 1 | 2002 | 87 | 0.010 |
Why?
| Receptors, Estrogen | 1 | 2002 | 130 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 2002 | 462 | 0.010 |
Why?
| Pyrazoles | 1 | 2002 | 111 | 0.010 |
Why?
| Estradiol | 1 | 2002 | 213 | 0.010 |
Why?
| Osteoporosis | 1 | 2002 | 155 | 0.010 |
Why?
| Quality of Life | 1 | 2007 | 837 | 0.010 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 824 | 0.010 |
Why?
| Adenocarcinoma | 1 | 2004 | 401 | 0.010 |
Why?
| Body Weight | 1 | 2002 | 512 | 0.010 |
Why?
| Risk Factors | 1 | 2006 | 3604 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2004 | 3136 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2002 | 1183 | 0.010 |
Why?
| Aged | 1 | 2004 | 9447 | 0.010 |
Why?
|
|
Fu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|